Eli Lilly & Co. closed $177.18 short of its 52-week high ($972.53), which the company reached on August 22nd. Supported by ...

After 10 long years, the company that has developed a collagen biomaterial to help heal tissue is readying itself for its ...

The ESMP platform enables marketing authorisation holders to report shortages and will be mandatory from 2025.

Swiss skincare company Galderma is banking on a drug for eczema treatment to revive sales growth at its pharmaceutical ...

American drugmaker Eli Lilly and Company's India unit is set to see a leadership change with managing director ...

Eli Lilly (LLY) is one of the stocks most watched by Zacks.com visitors lately. So, it might be a good idea to review some of the factors that might affect the near-term performance of the stock. Over ...